See also this year's filing and all EDGAR filings for this company.
PDF Report 0000874015_2014_Ionis_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.1642363942467189, 'aggregate_val': 698029000, 'exp_sum': 322529000, 'exp_to_value': {'LiabilitiesCurrent': 115332000, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 207197000}} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0000874015, Ionis Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 735,510,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 86,198,000 |
| 3 | remainder_Assets | 25,448,000 |
| 4 | LiabilitiesCurrent | 97,812,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 370,954,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,149,973 |
| 9 | ResearchAndDevelopmentExpense | -13,110,800 |
| 10 | remainder_Expenses | 42,861 |
| 11 | remainder_Revenues | 144,055,834 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 16,533,942 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 847,156,000 |
| 1 | Liabilities | 468,766,000 |
| 2 | Expenses | 2,082,034 |
| 3 | Revenues | 144,055,834 |
| 4 | StockholdersEquity | 378,390,000 |
| 5 | NetIncome | 141,973,800 |
| 6 | ComprehensiveNetIncome | 150,240,771 |
| 7 | BaseVar | 739,296,905 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.48 |
| 9 | EconomicCapitalRatio | 2.67 |
Edgar->Model Mapping
Feature Distribution
Change over Time
